Liver Disease Diagnostics Market Report 2025-2034: Industry Overview, Trends, And Forecast Analysis

Our market reports now include the latest updates on global tariffs, trade impacts, and evolving supply chain dynamics.

What Is the Current Liver Disease Diagnostics Market Size and Its Estimated Growth Rate?
The market size for the diagnosis of liver disease has seen substantial growth in recent times. We predict this market will expand from a value of $36.26 billion in 2024 to $39.05 billion in 2025, reflecting a compound annual growth rate (CAGR) of 7.7%. Factors responsible for the growth experienced in the historic period include heightened incidences of acute and chronic liver ailments, increased prevalence of liver diseases, higher alcohol consumption rates, elevated awareness regarding liver health, and improvements in healthcare infrastructure.

The market size for liver disease diagnostics is projected to experience significant expansion in the upcoming years. With a prediction of reaching $52.04 billion by 2029, a Compound Annual Growth Rate (CAGR) of 7.4% is anticipated. The factors contributing to this expansion during the forecast period include a growing elderly population, increased expenditure on research & development, a rise in the prevalence of biopsy procedures and diseases, and broader acceptance of telemedicine. Key trends during this period encompass the emergence of personalized medicine, advancements in diagnostic kit technology, progress in rapid tests, technological growth in the healthcare sector, and innovations in diagnostic methods.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20862

How Are Emerging Segments Shaping the Liver Disease Diagnostics Market Landscape?
The liver disease diagnostics market covered in this report is segmented -

1) By Diagnosis Technique: Laboratory Tests, Imaging, Endoscopy, Biopsy, Other Diagnosis Techniques
2) By Disease: Non-Alcoholic Fatty Liver Disease, Non-Alcoholic Steatohepatitis, Fibrosis, Cirrhosis, Hepatocellular Carcinoma, Other Diseases
3) By End Users: Hospitals, Laboratories, Other End Users

Subsegments:
1) By Laboratory Tests: Blood Tests (Liver Function Tests, Hepatitis Panel), Enzyme Tests (ALT, AST, ALP), Genetic Testing, Serological Tests
2) By Imaging: Ultrasound Imaging, CT Scans, MRI, Elastography (FibroScan)
3) By Endoscopy: Esophagogastroduodenoscopy (EGD), Capsule Endoscopy
4) By Biopsy: Liver Biopsy (Needle Biopsy), Fine Needle Aspiration Biopsy, Laparoscopic Biopsy
5) By Other Diagnosis Techniques: Molecular Imaging, Biomarker Testing, Fibrosis Scoring Systems

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20862&type=smp

Which Growth Factors Are Influencing Liver Disease Diagnostics Market Expansion?
The liver disease diagnostics market is anticipated to be driven by the rising consumption of alcohol. Factors such as changing societal norms, increased affordability and availability of alcohol, and growing stress or mental health issues contribute to this increased consumption. Liver disease diagnostics play a fundamental role in tracking the effects of alcohol on the condition of the liver, aiding in the early detection of conditions like fatty liver, hepatitis or cirrhosis. As per a report by the National Health Service, a government department in England, in December 2022, the proportion of individuals who consumed alcohol in the previous 12 months escalated with age, starting from 62% among 16 to 24-year olds, to 85% among individuals aged 55 to 74. Therefore, the growing consumption of alcohol is a key factor propelling the expansion of the liver disease diagnostics market.

Who Are the Dominant Players Across Different Liver Disease Diagnostics Market Segments?
Major companies operating in the liver disease diagnostics market are F. Hoffmann-La Roche Ltd., Abbott Laboratories, Thermo Fisher Scientific Inc., Fujifilm Holdings Corporation, Echosens SA, Boston Scientific Corporation, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Siemens Healthineers AG, bioMérieux SA, Genentech Inc., Perspectum Diagnostics Ltd., Owlstone Medical Ltd., Enterome SA, Atlentis Therapeutics AG, 89bio Inc., Aligos Therapeutics Inc., BioPredictive SAS, Cosara Diagnostics Pvt. Ltd., Hepion Pharmaceuticals Inc., HEPQuant LLC, Aiforia Technologies Plc

What Are the Latest Developing Trends in the Acne Treatment Devices Market?
Leading firms in the liver disease diagnostics market are concentrating on creating innovative solutions like non-invasive tools for liver evaluation to enhance diagnostic accuracy and efficiency. Non-invasive tools for liver evaluation encompass diagnostic methods that examine liver health using techniques such as elastography or blood analysis, thereby eliminating the necessity for invasive procedures such as biopsies. For example, in September 2024, FibroScan, a non-invasive diagnostic tool for liver evaluation, was introduced by City Imaging & Clinical, a diagnostic center based in India. This cutting-edge technology facilitates swift and precise measurements of liver stiffness and fat content, rendering invasive procedures like biopsies needless. The process is speedy, generally taking between 5 to 15 minutes, and includes the positioning of a probe on the skin above the liver. This probe produces sound waves measuring the rigidity of the liver tissue, thereby assisting in the evaluation of fibrosis or scarring.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/liver-disease-diagnostics-global-market-report

Which Geographic Regions Are Expected to Dominate the Liver Disease Diagnostics Market in the Coming Years?
North America was the largest region in the liver disease diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the liver disease diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Liver Disease Diagnostics Market?
2. What is the CAGR expected in the Liver Disease Diagnostics Market?
3. What Are the Key Innovations Transforming the Liver Disease Diagnostics Industry?
4. Which Region Is Leading the Liver Disease Diagnostics Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.